Organization
Meridian Bioscience, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Meridian Bioscience, Inc.
... Arroyo LLP announces that a class action complaint was filed against Meridian Bioscience, Inc. (NasdaqGS: VIVO). The complaint is brought on behalf of all purchasers ...
... investors that a class action lawsuit has been filed against Meridian Bioscience, Inc. ("Meridian Bioscience") (NASDAQ: VIVO) securities and certain of its officers, on behalf ...
... GENERAL HIGHLIGHTS CINCINNATI, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported fourth quarter and full-year fiscal 2017 net revenues ...
... Robbins Arroyo LLP is investigating whether certain officers and directors of Meridian Bioscience, Inc. (NasdaqGS: VIVO) violated federal laws. Meridian, a life science company, develops, ...
... State Building in New York City announces an investigation against Meridian Bioscience, Inc. (NASDAQ: VIVO)("Meridian" or the "Company") for possible violations of federal securities laws. ...
... Levi & Korsinsky announces it has commenced an investigation of Meridian Bioscience, Inc. (NASDAQ:VIVO) concerning possible violations of federal securities laws. The investigation concerns ...
... CINCINNATI, Oct. 23, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that the FDA has issued a Warning Letter ...
... CINCINNATI, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, expects to ...
... a new leader. John "Jack" Kenny was named CEO of Meridian Biosience Inc. (Nasdaq: VIVO) effective Oct. 9, the company announced. Kenny's appointment follows the ...
... CINCINNATI, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has appointed John (Jack) P. Kenny ...
... CINCINNATI, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that Magellan Diagnostics, Inc., a business unit of ...
... Life Science, Inc., (MLS) of Memphis, Tennessee, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the launch of TRU Block® ULTRA. This product ...
... WOBURN, Mass - Yield10 Bioscience, Inc. (NASDAQ:YTEN) today reported financial results for the three months ended June ...
... materially from those anticipated, including the risks and uncertainties detailed in Yield10 Bioscience's filings with the Securities and Exchange Commission. Yield10 Bioscience assumes no obligation ...
... CINCINNATI, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has initiated clinical trials for a ...
... CINCINNATI, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the expansion of its ImmunoCard STAT!® product line ...
... CINCINNATI, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that its Board of Directors elected a new ...
... GENERAL HIGHLIGHTS CINCINNATI, July 27, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported fiscal 2017 third quarter and first nine months ...
... The Klein Law Firm announces the commencement of an investigation of Meridian Bioscience, Inc. (NASDAQ: VIVO) concerning possible violations of federal securities laws. On January ...
... CINCINNATI, July 20, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the opening of Meridian Bioscience Beijing, LLC, its ...
... reviewing evidence collected during an inspection at Magellan, a unit of Meridian Bioscience Inc., to see if a US law was violated. The company's LeadCare ...
... leading national securities law firm, is investigating potential securities fraud at Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ:VIVO). The investigation focuses on whether the ...
... of Vincent Wong announce the commencement of an investigation concerning whether Meridian Bioscience, Inc. ("Meridian") (NASDAQ:VIVO) violated federal securities laws. Click here to learn about ...
... CINCINNATI, July 13, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO). Meridian Bioscience, Inc. is providing the following comments regarding the ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤